Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 433 entries
Sorted by: Best Match Show Resources per page
A Rare Case of Complicated Opioid Withdrawal in Delirium Without Convulsions.

Indian journal of psychological medicine

Raj BN, Manamohan N, Hegde D, Huded CB, Pradeep J.
PMID: 28515558
Indian J Psychol Med. 2017 Mar-Apr;39(2):191-193. doi: 10.4103/0253-7176.203109.

Opioids are one of the commonly abused substances in India. Opioid withdrawal symptoms classically include severe muscle cramps, bone aches, autonomic symptoms, anxiety, restlessness, insomnia, and temperature dysregulation. However, reports of cases with delirium during withdrawal are few. A...

Cite
Raj BN, Manamohan N, Hegde D, et al. A Rare Case of Complicated Opioid Withdrawal in Delirium Without Convulsions. Indian J Psychol Med. 2017;39(2):191-193doi: 10.4103/0253-7176.203109.
Raj, B. N., Manamohan, N., Hegde, D., Huded, C. B., & Pradeep, J. (2017). A Rare Case of Complicated Opioid Withdrawal in Delirium Without Convulsions. Indian journal of psychological medicine, 39(2), 191-193. https://doi.org/10.4103/0253-7176.203109
Raj, B Neeraj, et al. "A Rare Case of Complicated Opioid Withdrawal in Delirium Without Convulsions." Indian journal of psychological medicine vol. 39,2 (2017): 191-193. doi: https://doi.org/10.4103/0253-7176.203109
Raj BN, Manamohan N, Hegde D, Huded CB, Pradeep J. A Rare Case of Complicated Opioid Withdrawal in Delirium Without Convulsions. Indian J Psychol Med. 2017 Mar-Apr;39(2):191-193. doi: 10.4103/0253-7176.203109. PMID: 28515558; PMCID: PMC5385750.
Copy Download .nbib Format: NLM
Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions.

Hospital pharmacy

Ludtke KA, Stanley KS, Yount NL, Gerkin RD.
PMID: 26405310
Hosp Pharm. 2015 Mar;50(3):208-13. doi: 10.1310/hpj5003-208.

BACKGROUND: Alcohol withdrawal symptoms can be difficult to manage and may lead to an intensive care unit (ICU) admission. Patients experiencing severe alcohol withdrawal often require high doses of sedatives, which can lead to respiratory depression and the need...

Cite
Ludtke KA, Stanley KS, Yount NL, et al. Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions. Hosp Pharm. 2015;50(3):208-13doi: 10.1310/hpj5003-208.
Ludtke, K. A., Stanley, K. S., Yount, N. L., & Gerkin, R. D. (2015). Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions. Hospital pharmacy, 50(3), 208-13. https://doi.org/10.1310/hpj5003-208
Ludtke, Kimberly A, et al. "Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions." Hospital pharmacy vol. 50,3 (2015): 208-13. doi: https://doi.org/10.1310/hpj5003-208
Ludtke KA, Stanley KS, Yount NL, Gerkin RD. Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions. Hosp Pharm. 2015 Mar;50(3):208-13. doi: 10.1310/hpj5003-208. PMID: 26405310; PMCID: PMC4567190.
Copy Download .nbib Format: NLM
Use of a flumazenil infusion to treat chlordiazepoxide toxicity.

Acute medicine

Wallace IR, Campbell EC, Trimble M.
PMID: 28424803
Acute Med. 2017;16(1):30-34.

"Alcohol detox" is a common presentation to acute medical services and is usually managed via standardised guidelines and protocols. We present a case of chlordiazepoxide toxicity, requiring repeated bolus doses and subsequently 24 hours of an intravenous infusion of...

Cite
Wallace IR, Campbell EC, Trimble M. Use of a flumazenil infusion to treat chlordiazepoxide toxicity. Acute Med. 2017;16(1):30-34
Wallace, I. R., Campbell, E. C., & Trimble, M. (2017). Use of a flumazenil infusion to treat chlordiazepoxide toxicity. Acute medicine, 16(1), 30-34.
Wallace, I R, et al. "Use of a flumazenil infusion to treat chlordiazepoxide toxicity." Acute medicine vol. 16,1 (2017): 30-34.
Wallace IR, Campbell EC, Trimble M. Use of a flumazenil infusion to treat chlordiazepoxide toxicity. Acute Med. 2017;16(1):30-34. PMID: 28424803.
Copy Download .nbib Format: NLM
Unusual etiology of gastrointestinal symptoms: the case of jojoba butter.

Open access emergency medicine : OAEM

Minckler MR, Fisher J, Bowers R, Amini R.
PMID: 28223850
Open Access Emerg Med. 2017 Feb 07;9:27-29. doi: 10.2147/OAEM.S127273. eCollection 2017.

BACKGROUND: Jojoba butter is cyanogenic and has gained attention among herbal supplement consumers due to claims that it may aid in weight loss. Jojoba butter is extracted from the seeds of jojoba shrubs found in the Sonoran Desert. The...

Cite
Minckler MR, Fisher J, Bowers R, et al. Unusual etiology of gastrointestinal symptoms: the case of jojoba butter. Open Access Emerg Med. 2017;9:27-29doi: 10.2147/OAEM.S127273.
Minckler, M. R., Fisher, J., Bowers, R., & Amini, R. (2017). Unusual etiology of gastrointestinal symptoms: the case of jojoba butter. Open access emergency medicine : OAEM, 927-29. https://doi.org/10.2147/OAEM.S127273
Minckler, Michael R, et al. "Unusual etiology of gastrointestinal symptoms: the case of jojoba butter." Open access emergency medicine : OAEM vol. 9 (2017): 27-29. doi: https://doi.org/10.2147/OAEM.S127273
Minckler MR, Fisher J, Bowers R, Amini R. Unusual etiology of gastrointestinal symptoms: the case of jojoba butter. Open Access Emerg Med. 2017 Feb 07;9:27-29. doi: 10.2147/OAEM.S127273. eCollection 2017. PMID: 28223850; PMCID: PMC5304967.
Copy Download .nbib Format: NLM
[Prevention and Treatment of Common Acute Adverse Effects With Antipsychotic Use in Adults With Schizophrenia Diagnosis].

Revista colombiana de psiquiatria

Arenas Borrero ÁE, Gómez Restrepo C, Bohórquez Peñaranda AP, Vélez Traslaviña Á, Castro Díaz SM, Jaramillo González LE, García Valencia J.
PMID: 26576463
Rev Colomb Psiquiatr. 2014;44:66-74. doi: 10.1016/j.rcp.2015.05.009. Epub 2015 Jun 19.

OBJECTIVE: To determine the most adequate strategies for the prevention and treatment of the acute adverse effects of the use of antipsychotics.METHODS: A clinical practice guideline was elaborated under the parameters of the Methodological Guide of the Ministerio de...

Cite
Arenas Borrero ÁE, Gómez Restrepo C, Bohórquez Peñaranda AP, et al. Prevención y tratamiento de los efectos adversos agudos más frecuentes por el uso de antipsicóticos en pacientes adultos con diagnóstico de esquizofrenia. [Prevention and Treatment of Common Acute Adverse Effects With Antipsychotic Use in Adults With Schizophrenia Diagnosis]. Rev Colomb Psiquiatr. 2015;44:66-74doi: 10.1016/j.rcp.2015.05.009.
Arenas Borrero, �. �. E., Gómez Restrepo, C., Bohórquez Peñaranda, A. P., Vélez Traslaviña, �. �., Castro Díaz, S. M., Jaramillo González, L. E., & García Valencia, J. (2014). Prevención y tratamiento de los efectos adversos agudos más frecuentes por el uso de antipsicóticos en pacientes adultos con diagnóstico de esquizofrenia. [Prevention and Treatment of Common Acute Adverse Effects With Antipsychotic Use in Adults With Schizophrenia Diagnosis]. Revista colombiana de psiquiatria, 4466-74. https://doi.org/10.1016/j.rcp.2015.05.009
Arenas Borrero, Álvaro Enrique, et al. "Prevención y tratamiento de los efectos adversos agudos más frecuentes por el uso de antipsicóticos en pacientes adultos con diagnóstico de esquizofrenia." [Prevention and Treatment of Common Acute Adverse Effects With Antipsychotic Use in Adults With Schizophrenia Diagnosis]. Revista colombiana de psiquiatria vol. 44 (2014): 66-74. doi: https://doi.org/10.1016/j.rcp.2015.05.009
Arenas Borrero ÁE, Gómez Restrepo C, Bohórquez Peñaranda AP, Vélez Traslaviña Á, Castro Díaz SM, Jaramillo González LE, García Valencia J. Prevención y tratamiento de los efectos adversos agudos más frecuentes por el uso de antipsicóticos en pacientes adultos con diagnóstico de esquizofrenia. [Prevention and Treatment of Common Acute Adverse Effects With Antipsychotic Use in Adults With Schizophrenia Diagnosis]. Rev Colomb Psiquiatr. 2014;44:66-74. doi: 10.1016/j.rcp.2015.05.009. Epub 2015 Jun 19. Spanish. PMID: 26576463.
Copy Download .nbib Format: NLM
Posterior reversible encephalopathy syndrome-an under recognized manifestation of Chronic Kidney Disease.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

Kute VB, Trivedi HL, Shah PR, Gumber MR, Patel HV, Vanikar AV.
PMID: 24339647
Indian J Crit Care Med. 2013 Sep;17(5):318-20. doi: 10.4103/0972-5229.120329.

First Report of the Indian Chronic Kidney Disease (CKD) Registry showed that patient with CKD in India more frequently presented in Stage V. Many patients have uncontrolled hypertension and uremia due to noncompliance or non affordability of renal replacement...

Cite
Kute VB, Trivedi HL, Shah PR, et al. Posterior reversible encephalopathy syndrome-an under recognized manifestation of Chronic Kidney Disease. Indian J Crit Care Med. 2013;17(5):318-20doi: 10.4103/0972-5229.120329.
Kute, V. B., Trivedi, H. L., Shah, P. R., Gumber, M. R., Patel, H. V., & Vanikar, A. V. (2013). Posterior reversible encephalopathy syndrome-an under recognized manifestation of Chronic Kidney Disease. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 17(5), 318-20. https://doi.org/10.4103/0972-5229.120329
Kute, Vivek B, et al. "Posterior reversible encephalopathy syndrome-an under recognized manifestation of Chronic Kidney Disease." Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine vol. 17,5 (2013): 318-20. doi: https://doi.org/10.4103/0972-5229.120329
Kute VB, Trivedi HL, Shah PR, Gumber MR, Patel HV, Vanikar AV. Posterior reversible encephalopathy syndrome-an under recognized manifestation of Chronic Kidney Disease. Indian J Crit Care Med. 2013 Sep;17(5):318-20. doi: 10.4103/0972-5229.120329. PMID: 24339647; PMCID: PMC3841498.
Copy Download .nbib Format: NLM
Cysticercal encephalitis presenting with a "starry sky" appearance on neuroimaging.

Journal of global infectious diseases

Patil TB, Gulhane RV.
PMID: 25722618
J Glob Infect Dis. 2015 Jan-Mar;7(1):33-4. doi: 10.4103/0974-777X.150889.

A lady in her early forties was brought to our hospital in an unconscious state with history of generalized tonic-clonic seizures for last 6 h. She had multiple episodes of seizures in last 4 months, but did not receive...

Cite
Patil TB, Gulhane RV. Cysticercal encephalitis presenting with a "starry sky" appearance on neuroimaging. J Glob Infect Dis. 2015;7(1):33-4doi: 10.4103/0974-777X.150889.
Patil, T. B., & Gulhane, R. V. (2015). Cysticercal encephalitis presenting with a "starry sky" appearance on neuroimaging. Journal of global infectious diseases, 7(1), 33-4. https://doi.org/10.4103/0974-777X.150889
Patil, Tushar B, and Gulhane, Ragini V. "Cysticercal encephalitis presenting with a "starry sky" appearance on neuroimaging." Journal of global infectious diseases vol. 7,1 (2015): 33-4. doi: https://doi.org/10.4103/0974-777X.150889
Patil TB, Gulhane RV. Cysticercal encephalitis presenting with a "starry sky" appearance on neuroimaging. J Glob Infect Dis. 2015 Jan-Mar;7(1):33-4. doi: 10.4103/0974-777X.150889. PMID: 25722618; PMCID: PMC4338448.
Copy Download .nbib Format: NLM
Lorazepam provocation test in purported schizophrenia with lack of treatment response.

Mental illness

Berg JE.
PMID: 25553236
Ment Illn. 2014 Dec 18;6(2):5627. doi: 10.4081/mi.2014.5627. eCollection 2014 Sep 02.

Some patients with severe mental disorders are refractory to psychotherapeutic or psychopharmacological interventions. We present a patient who at the age of 19 developed several schizophrenia - suspect symptoms. Soon inexplicable general seizures where observed. He was treated with...

Cite
Berg JE. Lorazepam provocation test in purported schizophrenia with lack of treatment response. Ment Illn. 2014;6(2):5627doi: 10.4081/mi.2014.5627.
Berg, J. E. (2014). Lorazepam provocation test in purported schizophrenia with lack of treatment response. Mental illness, 6(2), 5627. https://doi.org/10.4081/mi.2014.5627
Berg, John E. "Lorazepam provocation test in purported schizophrenia with lack of treatment response." Mental illness vol. 6,2 (2014): 5627. doi: https://doi.org/10.4081/mi.2014.5627
Berg JE. Lorazepam provocation test in purported schizophrenia with lack of treatment response. Ment Illn. 2014 Dec 18;6(2):5627. doi: 10.4081/mi.2014.5627. eCollection 2014 Sep 02. PMID: 25553236; PMCID: PMC4274460.
Copy Download .nbib Format: NLM
An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice.

Journal of clinical and diagnostic research : JCDR

Bagewadi HG, Ak AK, Shivaramegowda RM.
PMID: 26435964
J Clin Diagn Res. 2015 Aug;9(8):FF01-5. doi: 10.7860/JCDR/2015/13233.6287. Epub 2015 Aug 01.

BACKGROUND: Due to the adverse effects produced by the present conventional medicines for anxiety disorders, research for newer drugs is still desirable. From the literature it is evident that NMDA receptors play a key role in animal models of...

Cite
Bagewadi HG, Ak AK, Shivaramegowda RM. An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice. J Clin Diagn Res. 2015;9(8):FF01-5doi: 10.7860/JCDR/2015/13233.6287.
Bagewadi, H. G., Ak, A. K., & Shivaramegowda, R. M. (2015). An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice. Journal of clinical and diagnostic research : JCDR, 9(8), FF01-5. https://doi.org/10.7860/JCDR/2015/13233.6287
Bagewadi, Harish G, et al. "An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice." Journal of clinical and diagnostic research : JCDR vol. 9,8 (2015): FF01-5. doi: https://doi.org/10.7860/JCDR/2015/13233.6287
Bagewadi HG, Ak AK, Shivaramegowda RM. An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice. J Clin Diagn Res. 2015 Aug;9(8):FF01-5. doi: 10.7860/JCDR/2015/13233.6287. Epub 2015 Aug 01. PMID: 26435964; PMCID: PMC4576556.
Copy Download .nbib Format: NLM
The effectiveness of ibuprofen and lorazepam combination therapy in treating the symptoms of acute Migraine: A randomized clinical trial.

Electronic physician

Rad RE, Ghaffari F, Fotokian Z, Ramezani A.
PMID: 28461864
Electron Physician. 2017 Mar 25;9(3):3912-3917. doi: 10.19082/3912. eCollection 2017 Mar.

BACKGROUND: Migraine is a common, episodic and debilitating disease. The migraineur not only suffers from pain, but also lives with a diminished to poor quality of life. Several medicinal therapies are used to abate the debilitating symptoms of this...

Cite
Rad RE, Ghaffari F, Fotokian Z, et al. The effectiveness of ibuprofen and lorazepam combination therapy in treating the symptoms of acute Migraine: A randomized clinical trial. Electron Physician. 2017;9(3):3912-3917doi: 10.19082/3912.
Rad, R. E., Ghaffari, F., Fotokian, Z., & Ramezani, A. (2017). The effectiveness of ibuprofen and lorazepam combination therapy in treating the symptoms of acute Migraine: A randomized clinical trial. Electronic physician, 9(3), 3912-3917. https://doi.org/10.19082/3912
Rad, Reza Ebrahimi, et al. "The effectiveness of ibuprofen and lorazepam combination therapy in treating the symptoms of acute Migraine: A randomized clinical trial." Electronic physician vol. 9,3 (2017): 3912-3917. doi: https://doi.org/10.19082/3912
Rad RE, Ghaffari F, Fotokian Z, Ramezani A. The effectiveness of ibuprofen and lorazepam combination therapy in treating the symptoms of acute Migraine: A randomized clinical trial. Electron Physician. 2017 Mar 25;9(3):3912-3917. doi: 10.19082/3912. eCollection 2017 Mar. PMID: 28461864; PMCID: PMC5407222.
Copy Download .nbib Format: NLM
Effects of Benzodiazepines on Acinar and Myoepithelial Cells.

Frontiers in pharmacology

Mattioli TM, Alanis LR, Sapelli Sda S, de Lima AA, de Noronha L, Rosa EA, Althobaiti YS, Almalki AH, Sari Y, Ignacio SA, Johann AC, Gregio AM.
PMID: 27445812
Front Pharmacol. 2016 Jun 24;7:173. doi: 10.3389/fphar.2016.00173. eCollection 2016.

BACKGROUND: Benzodiazepines (BZDs), the most commonly prescribed psychotropic drugs with anxiolytic action, may cause hyposalivation. It has been previously shown that BZDs can cause hypertrophy and decrease the acini cell number. In this study, we investigated the effects of...

Cite
Mattioli TM, Alanis LR, Sapelli Sda S, et al. Effects of Benzodiazepines on Acinar and Myoepithelial Cells. Front Pharmacol. 2016;7:173doi: 10.3389/fphar.2016.00173.
Mattioli, T. M., Alanis, L. R., Sapelli, S. d. a. . S., de Lima, A. A., de Noronha, L., Rosa, E. A., Althobaiti, Y. S., Almalki, A. H., Sari, Y., Ignacio, S. A., Johann, A. C., & Gregio, A. M. (2016). Effects of Benzodiazepines on Acinar and Myoepithelial Cells. Frontiers in pharmacology, 7173. https://doi.org/10.3389/fphar.2016.00173
Mattioli, Tatiana M F, et al. "Effects of Benzodiazepines on Acinar and Myoepithelial Cells." Frontiers in pharmacology vol. 7 (2016): 173. doi: https://doi.org/10.3389/fphar.2016.00173
Mattioli TM, Alanis LR, Sapelli Sda S, de Lima AA, de Noronha L, Rosa EA, Althobaiti YS, Almalki AH, Sari Y, Ignacio SA, Johann AC, Gregio AM. Effects of Benzodiazepines on Acinar and Myoepithelial Cells. Front Pharmacol. 2016 Jun 24;7:173. doi: 10.3389/fphar.2016.00173. eCollection 2016. PMID: 27445812; PMCID: PMC4919344.
Copy Download .nbib Format: NLM
Propylene Glycol Toxicity in Adolescent with Refractory Myoclonic Status Epilepticus.

Case reports in pediatrics

Bjur KA, Cannon BC, Fine AL, Ritter MJ, Schueler KE, Nemergut ME.
PMID: 28331645
Case Rep Pediatr. 2017;2017:2979486. doi: 10.1155/2017/2979486. Epub 2017 Feb 26.

Propylene glycol (PG) is a solvent commonly used in medications that, while benign at low doses, may cause toxicity in adults and children at high doses. We describe a case and the physiologic sequelae of propylene glycol toxicity manifested...

Cite
Bjur KA, Cannon BC, Fine AL, et al. Propylene Glycol Toxicity in Adolescent with Refractory Myoclonic Status Epilepticus. Case Rep Pediatr. 2017;2017:2979486doi: 10.1155/2017/2979486.
Bjur, K. A., Cannon, B. C., Fine, A. L., Ritter, M. J., Schueler, K. E., & Nemergut, M. E. (2017). Propylene Glycol Toxicity in Adolescent with Refractory Myoclonic Status Epilepticus. Case reports in pediatrics, 20172979486. https://doi.org/10.1155/2017/2979486
Bjur, Kara A, et al. "Propylene Glycol Toxicity in Adolescent with Refractory Myoclonic Status Epilepticus." Case reports in pediatrics vol. 2017 (2017): 2979486. doi: https://doi.org/10.1155/2017/2979486
Bjur KA, Cannon BC, Fine AL, Ritter MJ, Schueler KE, Nemergut ME. Propylene Glycol Toxicity in Adolescent with Refractory Myoclonic Status Epilepticus. Case Rep Pediatr. 2017;2017:2979486. doi: 10.1155/2017/2979486. Epub 2017 Feb 26. PMID: 28331645; PMCID: PMC5346383.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 433 entries